Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European Heart Journal. 2020;41(4):543-603. doi:10.1093/eurheartj/ehz405.
National Institute for Health and Care Excellence. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NICE guideline NG158. Published 2020, updated 2023, reviewed 2026.
Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Advances. 2020;4(19):4693-4738. doi:10.1182/bloodadvances.2020001830.
EINSTEIN-PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. New England Journal of Medicine. 2012;366(14):1287-1297. doi:10.1056/NEJMoa1113572.
Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism. New England Journal of Medicine. 2013;369(9):799-808. doi:10.1056/NEJMoa1302507.
Hokusai-VTE Investigators. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. New England Journal of Medicine. 2013;369(15):1406-1415. doi:10.1056/NEJMoa1306638.
Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. New England Journal of Medicine. 2014;370(15):1402-1411. doi:10.1056/NEJMoa1302097.
Zondag W, Mos ICM, Creemers-Schild D, et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. Journal of Thrombosis and Haemostasis. 2011;9(8):1500-1507. doi:10.1111/j.1538-7836.2011.04388.x.
Roy PM, Penaloza A, Hugli O, et al. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial. European Heart Journal. 2021;42(33):3146-3157. doi:10.1093/eurheartj/ehab373.
Jiménez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Archives of Internal Medicine. 2010;170(15):1383-1389. doi:10.1001/archinternmed.2010.199.
Aujesky D, Roy PM, Petit Le Manach C, et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. European Heart Journal. 2006;27(4):476-481. doi:10.1093/eurheartj/ehi588.